
DNA vs PRME
$DNA vs $PRME head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
DNA vs PRME: the quick read
- ·DNA is the larger company by market cap ($731M vs $707M).
- ·DNA has been more active on our scanner (329 vs 225 alerts in 30 days).
- ·DNA has the smaller float (62.0M vs 133.9M), which tends to mean sharper, more volatile moves.
- ·Both are biological products, (no diagnostic substances) names, so this is a like-for-like comparison and sector news tends to move them together.
- ·Both stay busy on our scanner, 329 and 225 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are closely matched in size, within 3% of each other on market cap, which makes the rest of this table the interesting part.
- ·PRME pays a dividend and DNA does not, which usually means one is being held for income and the other for the move.
- ·PRME is the one in play today, trading about 3.3x its normal volume, which is what puts a name on our scanner in the first place.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing DNA and PRME on TheDesperateTrader.
- Is DNA or PRME the better stock?
- "Better" depends on your goal, and these two are not alike. DNA is the larger company by market cap ($731M vs $707M). DNA has been more active on our scanner (329 vs 225 alerts in 30 days). DNA has the smaller float (62.0M vs 133.9M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between DNA and PRME?
- The differences that matter: they are similar in size ($731M vs $707M); they trade at very different share prices ($11.31 vs $3.88); DNA sits at 46% of its 52-week range against 29% for PRME; only PRME pays a dividend; our scanner flagged DNA 329 times in the last 30 days against 225 for PRME. Everything above is measured from the latest completed session and SEC filings.
- Which of DNA and PRME is more active right now?
- Right now DNA is at about 2.7x its normal volume and PRME is at about 3.3x, so PRME is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading DNA or PRME? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore DNA and PRME comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.